Published in Vaccine Weekly, March 3rd, 2004
The new study, The Emerging Cancer Vaccines Market: Worldwide Developments and Potential Markets, forecasts that the next 3 years will be very important ones for cancer vaccines. From late 2004 through 2007, there will probably be more than a dozen product launches, most in areas that have not yet seen a vaccine-based therapies. In addition to the more well know products on the way for melanoma and cervical cancer, there are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.